BIRAC Launches Dedicated Regulatory Affairs & Policy Advocacy Unit at BioNEST Conclave
BIRAC Launches Dedicated Regulatory Affairs & Policy Advocacy Unit at BioNEST Conclave

BIRAC Launches Dedicated Regulatory Affairs & Policy Advocacy Unit at BioNEST Conclave

SciFocus May 24, 2024 -- In a significant move to bolster India's biotech sector, the Biotechnology Industry Research Assistance Council (BIRAC) announced the establishment of a dedicated Regulatory Affairs & Policy Advocacy unit during the BioNEST Conclave on May 17, 2024, at the India International Centre (IIC), New Delhi.

Key Highlights:

- Purpose and Objectives:

- Facilitate the navigation of innovators through complex regulatory approval processes.

- Harmonize global regulations and advocate for policies that support the growth of startups, SMEs, and entrepreneurs.

- Strengthen evidence-based regulatory and policy frameworks in India.

- Key Speakers and Dignitaries:

- Dr. Rajeev Raghuvanshi, DCGI, CDSCO, emphasized regulations as facilitators of innovation.

- Dr. N. Kalaiselvi, Director General, CSIR & Secretary, DSIR, highlighted the importance of regulations in translating research to market-ready products.

- Prof. M. Jagadesh Kumar, Chairman, UGC, underscored the need for regulatory knowledge in universities and academic institutes.

- Dr. Alka Sharma, Senior Advisor, DBT, affirmed the initiative's potential to foster innovation and collaboration.

- Dr. Jitendra Kumar, MD-BIRAC, announced the collaboration with CDSCO, FSSAI, NITI Aayog, and other stakeholders to empower the biotech community.

- Unit’s Role and Impact:

- Aimed at driving innovation by navigating regulatory complexities.

- Expected to play a pivotal role in ensuring the smooth execution of BIRAC's innovation-focused objectives.

- Designed to bring various stakeholders together on a single platform for regulatory knowledge generation.

- Inaugural Remarks:

- Dr. Sonia Gandhi , Head of Regulatory Affairs & Policy Advocacy, BIRAC, concluded that the unit will be instrumental in navigating the intricate regulatory landscape.

This new division signifies a strategic step towards creating an enabling and empowering ecosystem for the biotech industry in India.

Source:


If you're enjoying this content, sign up to SciFocus daily newsletter by Biopatrika for all the biggest stories in Science, healthcare, STEM, startups, and how we're advocating to "Bring Science to Society."

For partnership or advertisement opportunities, feel free to contact us here or visit www.biopatrika.com.


Career Opportunities: Biopatrika Career Hub https://www.dhirubhai.net/groups/13946324/


Follow Virender Singh and Biopatrika on LinkedIn.



要查看或添加评论,请登录

Biopatrika的更多文章

社区洞察